Research ArticleBEHAVIORAL PHARMACOLOGY
Agmatine Induces Antihyperalgesic Effects in Diabetic Rats and a Superadditive Interaction with R(–)-3-(2-Carboxypiperazine-4-yl)-propyl-1-phosphonic Acid, a N-Methyl-d-aspartate-Receptor Antagonist
Christine Courteix, Anne-Marie Privat, Teresa Pélissier, Alejandro Hernandez, Alain Eschalier and Joseph Fialip
Journal of Pharmacology and Experimental Therapeutics September 2007, 322 (3) 1237-1245; DOI: https://doi.org/10.1124/jpet.107.123018
Christine Courteix
Anne-Marie Privat
Teresa Pélissier
Alejandro Hernandez
Alain Eschalier
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBEHAVIORAL PHARMACOLOGY
Agmatine Induces Antihyperalgesic Effects in Diabetic Rats and a Superadditive Interaction with R(–)-3-(2-Carboxypiperazine-4-yl)-propyl-1-phosphonic Acid, a N-Methyl-d-aspartate-Receptor Antagonist
Christine Courteix, Anne-Marie Privat, Teresa Pélissier, Alejandro Hernandez, Alain Eschalier and Joseph Fialip
Journal of Pharmacology and Experimental Therapeutics September 1, 2007, 322 (3) 1237-1245; DOI: https://doi.org/10.1124/jpet.107.123018
Research ArticleBEHAVIORAL PHARMACOLOGY
Agmatine Induces Antihyperalgesic Effects in Diabetic Rats and a Superadditive Interaction with R(–)-3-(2-Carboxypiperazine-4-yl)-propyl-1-phosphonic Acid, a N-Methyl-d-aspartate-Receptor Antagonist
Christine Courteix, Anne-Marie Privat, Teresa Pélissier, Alejandro Hernandez, Alain Eschalier and Joseph Fialip
Journal of Pharmacology and Experimental Therapeutics September 1, 2007, 322 (3) 1237-1245; DOI: https://doi.org/10.1124/jpet.107.123018
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement